SWM
GMED icon

Spire Wealth Management’s Globus Medical GMED Stock Holding History

Spire Wealth Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.11K Sell
90
-39
-30% -$3.31K ﹤0.01% 1739
2026
Q1 		$11.1K Sell
129
-430
-77% -$38.6K ﹤0.01% 1582
2025
Q4 		$48.8K Buy
559
+1
+0.2% +$76 ﹤0.01% 1189
2025
Q3 		$32K Sell
558
-2
-0.4% -$115 ﹤0.01% 1375
2025
Q2 		$33.1K Hold
560
– – ﹤0.01% 1349
2025
Q1 		$41K Hold
560
– – ﹤0.01% 1351
2024
Q4 		$46.3K Hold
560
– – ﹤0.01% 1314
2024
Q3 		$40.1K Sell
560
-38
-6% -$2.68K ﹤0.01% 1204
2024
Q2 		$41K Buy
598
+449
+301% +$26.8K ﹤0.01% 1184
2024
Q1 		$7.99K Hold
149
– – ﹤0.01% 1777
2023
Q4 		$8.42K Buy
+149
New +$7.26K ﹤0.01% 1801
2023
Q1 		– Sell
-192
Closed -$14K – 2520
2022
Q4 		$14K Buy
192
+5
+3% +$340 ﹤0.01% 1496
2022
Q3 		$11K Sell
187
-86
-32% -$5.18K ﹤0.01% 1535
2022
Q2 		$15K Sell
273
-226
-45% -$14.9K ﹤0.01% 1774
2022
Q1 		$37K Buy
499
+323
+184% +$22.5K ﹤0.01% 1556
2021
Q4 		$13K Hold
176
– – ﹤0.01% 2274
2021
Q3 		$13K Hold
176
– – ﹤0.01% 2006
2021
Q2 		$14K Hold
176
– – ﹤0.01% 2004
2021
Q1 		$11K Buy
+176
New +$11.1K ﹤0.01% 2378

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Spire Wealth Management's GMED Position: Q2 2026 in Review

Spire Wealth Management reduced its Globus Medical (GMED) stake by 30% in Q2 2026, selling an estimated $3.31K and leaving 90 shares worth $7.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Spire Wealth Management first reported a position in GMED in Q1 2021 and has held it in 19 quarters since. The position peaked at $48.8K in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Spire Wealth Management held 90 shares of Globus Medical worth $7.11K as of Q2 2026.
  • Spire Wealth Management sold 39 Globus Medical shares in Q2 2026, an estimated $3.31K.
  • Globus Medical made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1739 holding.
  • Spire Wealth Management first reported a position in Globus Medical in Q1 2021 and has held it in 19 quarters since.
  • Spire Wealth Management's Globus Medical position peaked at $48.8K in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.